Vanda Pharmaceuticals (VNDA) EPS (Diluted) (2010 - 2026)

Vanda Pharmaceuticals (VNDA) EPS (Diluted) (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 0.00
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.15
4 NuCana 279.75 Bn 279.75 Bn - -368,323.02
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 4.02
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 6.75
7 Belite Bio 62.51 Bn 62.51 Bn - 0.00
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 7.33
9 Revolution Medicines 37.78 Bn 37.78 Bn - -2.29
10 Vanda Pharmaceuticals 318.71 Mn 116.40 Mn 48.56 Mn -0.82

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.82
Dec 31, 2025 -2.40
Sep 30, 2025 -0.38
Jun 30, 2025 -0.46
Mar 31, 2025 -0.50
Dec 31, 2024 -0.08
Sep 30, 2024 -0.09
Jun 30, 2024 -0.08
Mar 31, 2024 -0.07
Dec 31, 2023 -0.04
Sep 30, 2023 0.00
Jun 30, 2023 0.03
Mar 31, 2023 0.06
Dec 31, 2022 0.12
Sep 30, 2022 0.06
Jun 30, 2022 0.05
Mar 31, 2022 -0.12
Dec 31, 2021 0.12
Sep 30, 2021 0.14
Jun 30, 2021 0.17